“Type-2-low” asthma is characterized by the absence of Th2 biomarkers and the presence of Th1 biomarkers, such as TNF-α, a proinflammatory cytokine involved in various aspects of airway pathology in asthma (Brightling et al., 2008). This evidence concerns the gene TNF and asthma.